\BOOKMARK [0][-]{section*.4}{Glossary}{}% 1
\BOOKMARK [0][-]{section*.6}{Acronyms}{}% 2
\BOOKMARK [0][-]{chapter*.7}{References}{}% 179
\BOOKMARK [0][-]{appendix.C}{Mutation Analysis in Breast Cancer}{}% 184
\BOOKMARK [1][-]{section.C.1}{Synthetic Lethal Genes and Pathways}{appendix.C}% 185
\BOOKMARK [1][-]{section.C.2}{Synthetic Lethal Expression Profiles}{appendix.C}% 186
\BOOKMARK [1][-]{section.C.3}{Comparison to Primary Screen}{appendix.C}% 187
\BOOKMARK [2][-]{subsection.C.3.1}{Resampling Analysis}{section.C.3}% 188
\BOOKMARK [1][-]{section.C.4}{Compare SLIPT genes}{appendix.C}% 189
\BOOKMARK [1][-]{section.C.5}{Metagene Analysis}{appendix.C}% 190
\BOOKMARK [1][-]{section.C.6}{Expression of Somatic Mutations}{appendix.C}% 191
\BOOKMARK [1][-]{section.C.7}{Metagene Expression Profiles}{appendix.C}% 192
\BOOKMARK [0][-]{appendix.D}{Intrinsic Subtyping}{}% 193
\BOOKMARK [0][-]{appendix.E}{Expression Analysis in Stomach Cancer}{}% 194
\BOOKMARK [1][-]{section.E.1}{Synthetic Lethal Genes and Pathways}{appendix.E}% 195
\BOOKMARK [1][-]{section.E.2}{Comparison to Primary Screen}{appendix.E}% 196
\BOOKMARK [2][-]{subsection.E.2.1}{Resampling Analysis}{section.E.2}% 197
\BOOKMARK [1][-]{section.E.3}{Metagene Analysis}{appendix.E}% 198
